References

Donate today and support our programs


Support for the HPV Toolkit is provided by Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc.


  1. Handsfield HH. Color Atlas and Synopsis of Sexually Transmitted Diseases. 3rd ed. New York, NY: McGraw-Hill; 2011:133-148.
  2. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56(RR-2):1-24.
  3. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-3044.
  4. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Burden of potentially human papillomavirus-associated cancer of the oropharynx and oral cavity in the US, 1998-2003. Cancer. 2008;113:2901-2909.
  5. American Society for Colposcopy and Cervical Pathology. Natural history of HPV. Accessed July 9, 2011.
  6. National Cancer Institute. Surveillance Epidemiology and End Results (SEER). Cancer of the cervix uteri: age-adjusted  US death rates by year, race, and age. Accessed May 21, 2012.
  7. National Cancer Institute. Surveillance Epidemiology and End Results (SEER). Cancer of the cervix uteri: Age-adjusted SEER incidence rates by year, race and age. Accessed May 21, 2012.
  8. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D for the 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. AJOG. 2007;197:346-355.
  9. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265.
  10. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the US. JAMA. 2007;297:813-819.
  11. American College of Obstetricians and Gynecologists (ACOG). Cervical cytology screening: ACOG practice bulletin 109. Obstet Gynecol. 2009;114:1409-1420.
  12. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer. 2007;121:621-632.
  13. American Society for Colposcopy and Cervical Pathology. HPV genotyping clinical update. Accessed May 21, 2012.
  14. Saslow, D., Solomon, D., Lawson, H. W., et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA: A Cancer Journal for Clinicians, 62: 147–172.
  15. U.S. Preventive Services Task Force. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement. AHRQ Publication No. 11-05156-EF-2, March 2012.
  16. American Congress of Obstetricians and Gynecologists. New Cervical Cancer Screening Recommendations from the U.S. Preventive Services Task Force and the American Cancer Society/American Society for Colposcopy and Cervical Pathology/American Society for Clinical Pathology. Accessed May 21, 2012
  17. Centers for Disease Control and Prevention. Fact Sheet: Genital HPV.
  18. Kodner CM, Nasraty S. Management of genital warts. Am Fam Physician. 2004;70:2335-2342.
  19. Smith-McCune K. Therapeutic options for genital warts.
  20. Wu X, Watson M, Wilson R, et al. Human Papillomavirus–Associated Cancers — United States, 2004–2008. MMWR, April 2012. 61(15):258-261.
  21. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2010;59:626-631.
  22. Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2010;59:630-632.
  23. Palefsky, J, Male Quadrivalent HPV Vaccine Efficacy Trial Team. Quadrivalent HPV vaccine efficacy against anal intraepithelial neoplasia in men having sex with men [Abstract]. Eurogin 9th International Multidisciplinary Congress, Monte Carlo, Monaco. February 17-20, 2010.
  24. Cervarix. [US prescribing information]. GlaxoSmithKline:2009.
  25. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR Morb Mortal Wkly Rep. 2010;59(RR-12):70-74.
  26. Imiquimod. [US prescribing information]. Graceway Pharmaceuticals, LLC.;2011.
  27. U.S. Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS Clinical Care. January 2011. Accessed online May 18, 2012.
  28. University of California, San Francisco AIDS Research Institute. Anal cancer: In gay and bisexual men. Accessed online May 21, 2012.
  29. Centers for Disease Control and Prevention. HPV and Men Fact Sheet. Accessed online May 18, 2012.
  30. American Society of Colon & Rectal Surgeons. Anal Cancer. Accessed online May 18, 2012.
  31. American Cancer Society. Detailed guide to cervical cancer. Accessed May 18, 2012.
  32. Hartmann L, Loprinzi C, eds. Mayo Clinic Guide to Women's Cancers. 1st ed. New York,NY: Mayo Clinic Health Information; 2005.
  33. American Cancer Society. Detailed Guide to Vulvar Cancer. Accessed online May 21, 2012.
  34. American Society for Colposcopy and Cervical Pathology. Human Papillomvirus Infections & Vulvar Intraepithelial Neoplasia. Accessed May 18, 2012.
  35. American Cancer Society. Detailed Guide to Vaginal Cancer. Accessed online May 21, 2012.
  36. American Society for Colposcopy and Cervical Pathology. Vaginal Neoplasia. Accessed May 18, 2012.
  37. American Cancer Society. Oral cavity and oropharyngeal cancers detailed guide. Accessed online May 21, 2012.
  38. Chaturvedi A,Engels E, Pfeiffer R, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29:4294–4301.
  39. American Cancer Society. Detailed Guide to Penile Cancer. Accessed online May 21, 2012.
  40. Stanford Medicine Cancer Institute. Diagnosis and Treatment of Penile Cancer. Accessed online May 21, 2012.
  41. Chaux A, Cubilla AL. The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin Diagn Pathol. 2012 May;29(2):67-71.
  42. Morris B, Gray R, Castellsague Z, Bosch FX, Halperin D, Waskett J, and Hankins C. The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol. 2011; doi: 10.1155/2011/812368l.
  43. Wood C, Whaley J. Penile Cancer: The Basics. Accessed online May 21, 2012.
  44. Senecal M, Brisson M, Maunsell E, Ferenczy A, Franco EL, Ratnam S, Coutlee F, et al. Loss of quality of life associated with genital warts:baseline analyses from a prospective study. Sex Transm Infect. 2011;87:209-215.
  45. Mortensen GL and Larsen HK.The quality of life of patients with genital warts:a qualitative study. BMC Public Health. 2010;10:1-8.